Identification of a novel splice-site WWOX variant with paternal uniparental isodisomy in a patient with infantile epileptic encephalopathy.
Megumi NishinoMai TanakaKazuo ImagawaKatsuyuki YaitaTakashi EnokizonoTatsuyuki OhtoHisato SuzukiMamiko YamadaToshiki TakenouchiKenjiro KosakiHidetoshi TakadaPublished in: American journal of medical genetics. Part A (2024)
WOREE syndrome is an early infantile epileptic encephalopathy characterized by drug-resistant seizures and severe psychomotor developmental delays. We report a case of a WWOX splice-site mutation with uniparental isodisomy. A 1-year and 7-month-old girl presented with nystagmus and epileptic seizures from early infancy, with no fixation or pursuit of vision. Physical examination revealed small deformities, such as swelling of both cheeks, folded fingers, rocking feet, and scoliosis. Brain imaging revealed slight hypoplasia of the cerebrum. Electroencephalogram showed focal paroxysmal discharges during the interictal phase of seizures. Vitamin B6 and zonisamide were administered for early infantile epileptic encephalopathy; however, the seizures were not relieved. Despite altering the type and dosage of antiepileptic drugs and ACTH therapy, the seizures were intractable. Whole-exome analysis revealed the homozygosity of WWOX(NM_016373.4):c.516+1G>A. The WWOX mRNA sequencing using peripheral blood RNA confirmed that exon 5 was homozygously deleted. Based on these results, the patient was diagnosed with WOREE syndrome at 5 months. The WWOX variant found in this study is novel and has never been reported before. WOREE syndrome being extremely rare, further case series and analyses of its pathophysiology are warranted.
Keyphrases
- drug resistant
- case report
- early onset
- single cell
- temporal lobe epilepsy
- peripheral blood
- multidrug resistant
- acinetobacter baumannii
- mental health
- atrial fibrillation
- physical activity
- photodynamic therapy
- minimally invasive
- stem cells
- bone marrow
- white matter
- resting state
- copy number
- brain injury
- multiple sclerosis
- drug induced
- cell therapy
- nucleic acid
- fluorescence imaging